These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2742731)

  • 41. Cortical and subcortical influences on clustering and switching in the performance of verbal fluency tasks.
    Tröster AI; Fields JA; Testa JA; Paul RH; Blanco CR; Hames KA; Salmon DP; Beatty WW
    Neuropsychologia; 1998 Apr; 36(4):295-304. PubMed ID: 9665640
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cognitive impairment in early-stage non-demented Parkinson's disease patients.
    Pfeiffer HC; Løkkegaard A; Zoetmulder M; Friberg L; Werdelin L
    Acta Neurol Scand; 2014 May; 129(5):307-18. PubMed ID: 24117192
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Screening for cognitive deficits in Parkinson's disease with the Parkinson neuropsychometric dementia assessment (PANDA) instrument.
    Kalbe E; Calabrese P; Kohn N; Hilker R; Riedel O; Wittchen HU; Dodel R; Otto J; Ebersbach G; Kessler J
    Parkinsonism Relat Disord; 2008; 14(2):93-101. PubMed ID: 17707678
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The frontal assessment battery as a tool for evaluation of frontal lobe dysfunction in patients with Parkinson disease.
    Cohen OS; Vakil E; Tanne D; Molshatzki N; Nitsan Z; Hassin-Baer S
    J Geriatr Psychiatry Neurol; 2012 Jun; 25(2):71-7. PubMed ID: 22689698
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential memory and executive functions in demented patients with Parkinson's and Alzheimer's disease.
    Litvan I; Mohr E; Williams J; Gomez C; Chase TN
    J Neurol Neurosurg Psychiatry; 1991 Jan; 54(1):25-9. PubMed ID: 2010755
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relationship between neuropsychological tests and driver's license renewal tests in Parkinson's disease.
    Badenes D; Garolera M; Casas L; Cejudo-Bolivar JC; Zaragoza S; Calzado N; Aguilar M
    Traffic Inj Prev; 2018 Feb; 19(2):125-132. PubMed ID: 28759268
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Normal release from proactive interference in untreated patients with Parkinson's disease.
    Sagar HJ; Sullivan EV; Cooper JA; Jordan N
    Neuropsychologia; 1991; 29(11):1033-44. PubMed ID: 1775225
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Frontal and posterior subtypes of neuropsychological deficit in Parkinson's disease.
    Miller IN; Neargarder S; Risi MM; Cronin-Golomb A
    Behav Neurosci; 2013 Apr; 127(2):175-183. PubMed ID: 23398433
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neuropsychological profile in patients with early stage of Parkinson's disease in Taiwan.
    Yu RL; Wu RM; Tai CH; Lin CH; Cheng TW; Hua MS
    Parkinsonism Relat Disord; 2012 Dec; 18(10):1067-72. PubMed ID: 22749792
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mild cognitive impairment in Parkinson's disease versus Alzheimer's disease.
    Besser LM; Litvan I; Monsell SE; Mock C; Weintraub S; Zhou XH; Kukull W
    Parkinsonism Relat Disord; 2016 Jun; 27():54-60. PubMed ID: 27089852
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Using the Cambridge Neuropsychological Test Automated Battery (CANTAB) to assess the cognitive impact of electroconvulsive therapy on visual and visuospatial memory.
    Falconer DW; Cleland J; Fielding S; Reid IC
    Psychol Med; 2010 Jun; 40(6):1017-25. PubMed ID: 19775495
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Brief cognitive assessment in the early stages of Parkinson disease.
    Bugalho P; Vale J
    Cogn Behav Neurol; 2011 Dec; 24(4):169-73. PubMed ID: 22045168
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Visuospatial working memory in Parkinson's disease.
    Bradley VA; Welch JL; Dick DJ
    J Neurol Neurosurg Psychiatry; 1989 Nov; 52(11):1228-35. PubMed ID: 2592967
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neuropsychological and psychiatric differences between Alzheimer's disease and Parkinson's disease with dementia.
    Starkstein SE; Sabe L; Petracca G; Chemerinski E; Kuzis G; Merello M; Leiguarda R
    J Neurol Neurosurg Psychiatry; 1996 Oct; 61(4):381-7. PubMed ID: 8890777
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study.
    Aarsland D; Brønnick K; Larsen JP; Tysnes OB; Alves G;
    Neurology; 2009 Mar; 72(13):1121-6. PubMed ID: 19020293
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Object alternation and orbitofrontal system dysfunction in Alzheimer's and Parkinson's disease.
    Freedman M
    Brain Cogn; 1990 Nov; 14(2):134-43. PubMed ID: 2285509
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Visuospatial memory deficits at different stages of Parkinson's disease.
    Owen AM; Beksinska M; James M; Leigh PN; Summers BA; Marsden CD; Quinn NP; Sahakian BJ; Robbins TW
    Neuropsychologia; 1993 Jul; 31(7):627-44. PubMed ID: 8371837
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Memory and executive function impairment predict dementia in Parkinson's disease.
    Levy G; Jacobs DM; Tang MX; Côté LJ; Louis ED; Alfaro B; Mejia H; Stern Y; Marder K
    Mov Disord; 2002 Nov; 17(6):1221-6. PubMed ID: 12465060
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Building and validation of a test evaluating verbal recognition memory: The Forty test (f40)].
    Marqué A; Hommet C; Constans T; Perrier D; Bardet F; Chaput M; Mondon K
    Rev Neurol (Paris); 2011 Apr; 167(4):324-30. PubMed ID: 21195442
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Frontal dysfunction contributes to the genesis of hallucinations in non-demented Parkinsonian patients.
    Grossi D; Trojano L; Pellecchia MT; Amboni M; Fragassi NA; Barone P
    Int J Geriatr Psychiatry; 2005 Jul; 20(7):668-73. PubMed ID: 16021658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.